0001628280-24-011026.txt : 20240313 0001628280-24-011026.hdr.sgml : 20240313 20240313183747 ACCESSION NUMBER: 0001628280-24-011026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240308 FILED AS OF DATE: 20240313 DATE AS OF CHANGE: 20240313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DuRoss Amy CENTRAL INDEX KEY: 0001854968 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36362 FILM NUMBER: 24747362 MAIL ADDRESS: STREET 1: 8410 GOLDEN BEAR PLACE CITY: WHISTLER STATE: A1 ZIP: V8E 1J7 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC CENTRAL INDEX KEY: 0000834365 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 943076866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4254011400 MAIL ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: BIOLIFE SOLUTION INC DATE OF NAME CHANGE: 20030113 FORMER COMPANY: FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC DATE OF NAME CHANGE: 19920703 4 1 wk-form4_1710369455.xml FORM 4 X0508 4 2024-03-08 0 0000834365 BIOLIFE SOLUTIONS INC BLFS 0001854968 DuRoss Amy 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 1 0 0 0 0 Common Stock 2024-03-08 4 A 0 11264 A 40643 D Common Stock 2024-03-12 4 S 0 6135 16.86 D 34508 D Common Stock 2024-03-13 4 S 0 5065 17 D 29443 D The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan (the "2023 Plan") and fully vests on the first anniversary of the grant date. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.60 to $17.11, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Amy DuRoss 2024-03-13